A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

The field of genetic vaccines has emerged as a transformative area in immunology, particularly with the advent of platforms delivering engineered nucleic ...

An agentic coding tool tasked with cloning and setting up a seemingly benign GitHub repository could execute a malicious ...

In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...

Genetic mutations that drive cancer often occur in tumor suppressor proteins, including the p53 transcription factor which is altered in ~40-50% of cases 1,2. However, current therapies fail to target ...